Clinical analysis of the correlation between serum IL-10 and testosterone with coronary artery disease.
10.3760/cma.j.issn.1008-6315.2009.09.014
- VernacularTitle:白细胞介素-10和睾酮与冠心病的相关性分析
- Author:
Xiaochen WANG
;
Yan XU
;
Ziping CHENG
;
Banglong XU
;
Bin CHEN
;
Xuhua CHEN
;
Mengzuo WU
;
Xianhe LIN
;
Runshuo ZHU
- Publication Type:Journal Article
- Keywords:
Interleukin-10;
Testosterone;
Coronary heart disease
- From:
Clinical Medicine of China
2009;25(9):935-938
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the correlation between seram interleukin-10 (IL-10) and testosterone with coronary heart disease (CHD). Methods 387 patients were divided into CHD group (n = 239) and control group ( n = 148 ) according to the results of coronary angiography. CHD patients were divided into subgroups accord-ing to the numbers, Gensini score of lesions in the coronary arteries and clinical severity ( statue of stable coronary artery disease, unstable angina or acute myocardial infarction). Serum IL-10 and testosterone levels were measured by ELASA. Logistic regression and partial correlation were used to evaluate the correlation of serum IL-10 and testoster-one with CHD. Results IL-10 was significantly lower in the CHD group than in the control group[ (39.08 ± 14.22) ng/L vs (49.27 ± 24.67)ng/L, P < 0. 001 ]. The partial correlation analysis results in subgroups showed that the correlation coefficient of IL-10 with number of lesions,gensini score and clinical severity of CHD was - 0.25, P < 0.001, -0.25 ,P <0.05 and -0.25 ,P <0.001 ,respectively. Serum testosterone had no difference in control group and CHD group (P >0.05 ). Logistic regression analysis found that only smoking (OR = 3.79,95% CI 2.09～ 6.84,P<0.01) ,diabetes mellitus (OR =2.48,95% CI 1.05 ～5.88,P <0. 05) ,apoB ( OR = 14.3,95% CI 4.29～46.61 ,P <0.01 ) and IL-10 ( OR =0.74,95%, CI 0.57～0.89 ,P <0.01 ) entered the model. Conclusions Serum IL-10 is not only significantly correlated with CHD but also with its severity. IL-10 is an independent pro-tective factor for CHD.
